Attovia Therapeutics, Inc. (ATTO)

NASDAQ: ATTO · Real-Time Price · USD

23.00

-0.66 (-2.79%)

Sep 9, 2026, 3:14 PM EDT - Market open

Attovia Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	1,050	-	-
Market Cap Growth	-	-	-
Enterprise Value	939	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.04	0.04	-
Net Debt / Equity Ratio	-0.98	-0.97	-1.12
Net Debt / EBITDA Ratio	1.47	2.22	1.68
Net Debt / FCF Ratio	1.62	2.39	1.88
Asset Turnover	-	0.01	-
Quick Ratio	9.20	13.92	8.99
Current Ratio	9.39	14.20	9.39
Return on Equity (ROE)	-	-56.95%	-
Return on Assets (ROA)	-	-34.60%	-
Return on Capital Employed (ROCE)	-65.80%	-43.40%	-60.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Buyback Yield / Dilution	-	-11.84%	-

SEC Filings: 10-K · 10-Q